Meet the First Authors.

Abstract

HomeCirculation ResearchVol. 131, No. 8Meet the First Authors Free AccessIn BriefPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessIn BriefPDF/EPUBMeet the First Authors Originally published29 Sep 2022https://doi.org/10.1161/RES.0000000000000574Circulation Research. 2022;131:652–653is related toExtracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart FailureThe Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell FunctionImpaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2is related toTranscriptional and Immune Landscape of Cardiac SarcoidosisCardiac Sarcoidosis Immune Landscape (p 654)Download figureDownload PowerPointDr Jing Liu ia a resident doctor of Medicine (Cardiology). She earned her MD from Xi’an Jiaotong University and completed her medicine internship followed by a PhD program (Cardiovascular Medicine) at Xi’an Jiaotong University. She completed her PhD joint training program at Washington University in St. Louis. Supervised by Dr Kory Lavine, Dr Liu took a deep interest in cardiac immunology and set her future research focus on biological, cellular and immune mechanisms of heart failure and coronary disease. Dr Liu has published five manuscripts so far and hopes to make fundamental discoveries in cardiovascular medicine.Download figureDownload PowerPointDr Pan Ma is a postdoctoral researcher in Washington University in Saint Louis, School of Medicine. She earned her PhD from Institution of Biophysics, University of Chinese Academy of Sciences in tumor immunology and her MS from Institution of Microbiology, University of Chinese Academy of Sciences in immunology. These research experiences sparked her interest in tumor therapy-induced myocarditis and other forms of myocarditis. Her current research includes exploring the immune landscape in immune checkpoint inhibitors associated myocarditis as well as macrophage diversity in cardiac sarcoidosis and defining the spatial transcriptomic landscape of myocarditis using single-cell and spatial technologies.Impaired Dynamic SR Ca Buffering Causes AD-CPVT2 (p 673)Download figureDownload PowerPointMatthew Wleklinski is an MD/PhD student interested in the molecular and tissue mechanisms of cardiac arrhythmias and sudden death. His dissertation research focused on the protein calsequestrin and its role in catecholaminergic polymorphic ventricular tachycardia. His research career began as an undergraduate student at the University of Wisconsin-Madison, where he earned a BS in Pharmacology/Toxicology. After developing an interest in both medicine and research, he applied to and has been training in Vanderbilt’s Medical Scientist Training Program. His goal is to become a physician-scientist that specializes in pediatric cardiology.EV-Mediated Heart Brain Communication in CHF (p 687)Download figureDownload PowerPointDr Changhai Tian is an independent Assistant Professor at the University of Kentucky College of Medicine. He earned his PhD from the Chinese Academy of Sciences and then started his postdoctoral training at the University of Nebraska Medical Center (UNMC), focusing on redox regulation in cancers and neurodegenerative disorders. He has now expanded his research to the cardiovascular field and collaborated with Dr Irving Zucker (UNMC) to investigate the underlying mechanisms by which the heart communicates with the brain in the pathogenesis of heart failure and, especially, the role of extracellular vesicles in inter-organ communication. Outside of work, he enjoys cooking and fishing.Homoarginine Reduces Atherosclerosis (p 701)Download figureDownload PowerPointDr Katrin Nitz is a postdoctoral fellow in the lab of Dr Dorothee Atzler and Dr Esther Lutgens at the Institute for Cardiovascular Prevention (IPEK, LMU Munich) in Germany. Katrin studied Molecular Medicine at theUniversity of Freiburg and continued as a PhD student at the Max-Delbruck-Centrum in Berlin to study the role of neutrophils in atherosclerosis. Her current focus at IPEK is to study amino acid metabolisms in T cells in atherosclerosis. Outside of work, she is enthusiastic about cycling and getting creative with photography.Download figureDownload PowerPointDr Michael Lacy is an Assistant Professor in Immunology in the department of Medical Laboratory Sciences at Virginia Commonwealth University in Richmond, VA. Dr Lacy earned his PhD from Ludwig Maximilian University of Munich in Germany under the supervision of Dr Dorothee Atzler and Dr Esther Lutgens at the Institute for Cardiovascular Prevention (IPEK). His research interests involve developing therapies to target T cells in atherosclerosis. Currently, he is investigating the role of chromatin remodeling enzymes on T cell phenotypes and their impact on atherosclerosis. Outside of the lab, he enjoys traveling as well as discovering local highlights closer to home. Previous Back to top Next FiguresReferencesRelatedDetailsRelated articlesExtracellular Vesicles Regulate Sympatho-Excitation by Nrf2 in Heart FailureChanghai Tian, et al. Circulation Research. 2022;131:687-700The Amino Acid Homoarginine Inhibits Atherogenesis by Modulating T-Cell FunctionKatrin Nitz, et al. Circulation Research. 2022;131:701-712Impaired Dynamic Sarcoplasmic Reticulum Ca Buffering in Autosomal Dominant CPVT2Matthew J. Wleklinski, et al. Circulation Research. 2022;131:673-686Transcriptional and Immune Landscape of Cardiac SarcoidosisJing Liu, et al. Circulation Research. 2022;131:654-669 September 30, 2022Vol 131, Issue 8 Advertisement Article InformationMetrics © 2022 American Heart Association, Inc.https://doi.org/10.1161/RES.0000000000000574PMID: 36173823 Originally publishedSeptember 29, 2022 PDF download Advertisement